ESC
iPSC — Pulmonary

iPSC-Derived Lung Organoids & Airway Epithelium

I differentiate iPSCs into lung progenitors, distal alveolospheres (alveolar type 2–like), and proximal airway organoids using sequential definitive endoderm → anterior foregut → lung patterning. These models recapitulate ACE2/TMPRSS2 expression for SARS-CoV-2 entry studies, surfactant biology for IPF / surfactant-deficiency disorders, and ciliated/goblet-cell biology for cystic fibrosis and asthma research.

DE → AFG → Lung Alveolospheres SARS-CoV-2 IPF / Surfactant RNA-seq
01

Definitive Endoderm to NKX2.1+ Lung Progenitors

Following the Hawkins/Kotton-style protocol, iPSCs are committed to definitive endoderm with Activin A, ventralized to anterior foregut by dual-SMAD inhibition, and patterned to NKX2.1+ lung-fated progenitors with FGF7, FGF10, BMP4, and retinoic acid. Sorting on CD47hi/CD26lo isolates lung progenitors that further differentiate into distal SFTPC+ alveolospheres (3D Matrigel) or proximal multiciliated airway epithelium (air-liquid interface).

Differentiation Timeline
iPSC → DE → Anterior Foregut → Lung Progenitor → Alveolosphere / Airway
Day 0–3
Definitive Endoderm
SOX17 · FOXA2 · CXCR4
Activin A 100 ng/mL + CHIR99021 3 µM (day 1).
Day 3–6
Anterior Foregut
SOX2 · FOXA2
Dual-SMAD: Dorsomorphin + SB431542; ventralize away from posterior endoderm.
Day 6–15
Lung Progenitor
NKX2.1 · FOXA2 · SOX9
FGF7 (10 ng/mL) + FGF10 (10 ng/mL) + BMP4 (10 ng/mL) + retinoic acid (50 nM).

Dual-SMAD: Dorsomorphin 2 µM + SB431542 10 µM in SFD basal medium. Drives away from posterior endoderm toward anterior foregut.

Day 15–25
Sort & Branch
CD47hi · CD26lo
FACS to enrich NKX2.1+ progenitors. Branch to distal vs proximal lineages.

FACS on CD47hi/CD26lo to enrich NKX2.1+ progenitors; alternatively use the NKX2.1GFP reporter. Branch into distal (alveolar) vs proximal (airway).

Day 25–45
Alveolosphere (distal)
SFTPC · SFTPB · ABCA3
3D Matrigel + CHIR + KGF + dexamethasone + cAMP + IBMX.

Embed in 3D Matrigel; mature in CHIR + KGF + dexamethasone + cAMP + IBMX (CK+DCI). SFTPC+/SFTPB+ AT2-like cells with lamellar bodies (visible by EM).

Day 25–45
Airway (proximal)
FOXJ1 · MUC5AC · SCGB1A1
ALI culture on Transwells in PneumaCult-ALI; 3+ weeks for ciliated cells.

Plate on Transwell inserts; expand submerged in PneumaCult-Ex Plus, then air-liquid interface for 3+ weeks. FOXJ1+ multiciliated cells with beating cilia (visible by video) + MUC5AC+ goblet cells.

  1. Definitive endoderm (Day 0–3)

    High-density iPSCs in RPMI + Activin A + CHIR (Day 1 only); validate >80% SOX17+/FOXA2+.

  2. Anterior foregut (Day 3–6)

    Switch to SFD basal medium with dual-SMAD inhibition: Dorsomorphin (2 µM) + SB431542 (10 µM).

  3. Lung patterning (Day 6–15)

    Switch to FGF7 + FGF10 + BMP4 + RA in CBFRA medium for ~10 days. Quantify NKX2.1+ progenitors.

  4. Progenitor enrichment (Day 15)

    FACS sort on CD47hi/CD26lo for high-purity NKX2.1+ lung progenitors (alternatively use NKX2.1GFP reporter line).

  5. Distal: alveolospheres

    Embed sorted progenitors in Matrigel droplets; mature in CHIR + KGF + dexamethasone + cAMP + IBMX (CK+DCI). SFTPC+ alveolospheres by Day 35–45.

  6. Proximal: ALI airway

    Plate progenitors on Transwell inserts; expand submerged in PneumaCult-Ex Plus, then ALI for 3+ weeks. Validate beating cilia (FOXJ1+, video) and goblet cells (MUC5AC).

>30%
NKX2.1+ lung progenitors
SFTPC+
distal alveolospheres at D40
FOXJ1+
multiciliated airway by ALI D21
ACE2+
SARS-CoV-2 entry permissive
02

Distal Alveolar Type-2–Like Cells

Alveolospheres self-organize into spherical cysts of pro-SFTPC+/SFTPB+/ABCA3+ AT2-like cells with apical lumens. Lamellar bodies are visible by EM, and surfactant secretion can be quantified by ELISA. These structures permit modeling of surfactant deficiency (SFTPC mutations), IPF (telomere-dysfunction lines), and viral infection.

NKX2.1 SFTPC SFTPB ABCA3 HOPX AGER
03

ACE2 / TMPRSS2 Entry & Antiviral Profiling

iPSC-derived AT2-like cells express ACE2 and TMPRSS2 and are productively infected by SARS-CoV-2 spike-pseudotyped lentiviruses and authentic virus (BSL-3). I have used analogous systems (Calu-3 epithelial cells) for spike-uptake assays and antiviral entry-inhibitor screens. See related work on the endocytosis page.

04

Surfactant Deficiency & Fibrosis Modeling

SFTPCI73T mutant alveolospheres show ER stress, impaired surfactant trafficking, and proteostatic collapse, modeling familial IPF. Co-culture with iPSC-derived mesenchyme in cytokine-driven fibrotic medium (TGFβ, IL-13) recapitulates myofibroblast activation and ECM deposition for anti-fibrotic compound screens.

99

Identity Confirmation — Lung Lineages

NKX2.1+ progenitor purity is monitored by flow cytometry (or via the NKX2.1GFP reporter line); distal alveolosphere identity is confirmed by SFTPC/SFTPB/ABCA3, and proximal airway identity by FOXJ1 (multiciliated) and MUC5AC (goblet).

Flow Cytometry — % Marker-Positive (Lung Progenitors / Alveolosphere)
Mean ± SEM, n = 3 differentiations
Representative values from typical batches. Aim values: lineage-defining markers > 70% in late-stage cells.
RT-qPCR — Alveolosphere vs iPSC (log₂ FC)
ΔΔCt method · housekeeping: GAPDH, ACTB · n = 3
Bars above zero = up-regulated; bars below zero = down-regulated relative to undifferentiated iPSC.